Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12616001120460Phase 4Completed
Phase 4, randomised, open-label trial of propofol and sevoflurane (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Total volume of nasopharyngeal secretions. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12616001120460.